Back to search results

Understanding Quality of Care in Telemedicine for Brain Cancer

This observational study, NCT04988009, aims to understand how patients with brain tumors (primary brain tumors, brain metastases, or leptomeningeal disease) perceive the quality of their care, especially when using telemedicine (virtual appointments). Researchers will compare experiences between telemedicine and in-person visits by reviewing medical charts and asking patients to complete a survey. The main goal is to see if patients feel they received good medical care during their appointments. This study hopes to enroll 200 participants and will follow their survey responses for about one year to help doctors improve how they deliver care through telemedicine.

Study design
This is an observational study that plans to include 200 participants. It compares patient experiences between telemedicine and in-person visits.
What's involved
You would complete a survey about your quality of care via telephone, and your medical chart would be reviewed.
Compensation
Not stated in the trial record.
Follow-up
Your survey responses will be measured through study completion, which is an average of one year.

AI-generated from the public study record. Only the study team can confirm whether you're eligible — confirm details with them before making decisions.

NCT04988009

Patient Perceptions Around Quality of Care Through Telemedicine in Neuro-Oncology

Recruiting
Not specifiedAges 18+Observational
M.D. Anderson Cancer Center
~200 participants
Updated 2026-03-05 on ClinicalTrials.gov
What's tested:Electronic Health Record ReviewSurvey Administration

At a glance

Recruiting sites
1 of 1 listed site is recruiting right now
RecruitingSuspended, closed, or not yet open
What they're measuring
Survey response to question 6 of the quality of care survey ("I felt I received good medical care during this encounter")
Measured over through study completion, an average of 1 year

Conditions

Central Nervous System Neoplasm
Leptomeningeal Neoplasm
Metastatic Malignant Neoplasm in the Brain
Primary Brain Neoplasm

Explore related trials

Central Nervous System NeoplasmLeptomeningeal NeoplasmMetastatic Malignant Neoplasm in the BrainPrimary Brain Neoplasm

Where it's being run

1 sites across 1 states
Texas1

Study leadership

  • Barbara J O'Brien, MD · PRINCIPAL_INVESTIGATOR · M.D. Anderson Cancer Center

Who to contact

Barbara J O'Brien, MD
[email protected]
713-794-4380
Email the study team

Opens a ready-to-send draft in your own email app — review before sending.

Do you actually qualify for this trial?

Add a private profile and we'll compare every criterion below against your situation — and tell you which ones are met, uncertain, or excluding.

Check eligibility for this trial ~2 min · HIPAA-protected · delete anytime
Eligibility criteria

Inclusion

Patients with a CNS tumors: this includes patients with primary brain tumors, brain metastases, and leptomeningeal disease
Established patients with a follow up encounter with Neuro-Oncology at the Brain and Spine Center at the University of Texas MD Anderson Cancer Center; this encounter can be
An in-person visit
A telemedicine appointment

Exclusion

Encounter occurred with the assistance of official language translation support
Patients with telephone encounters (without interactive video)
New patient or consult visits
Neither patient nor caregiver present during the visit are available or able to answer survey questions

What this trial measures

  • Survey response to question 6 of the quality of care survey ("I felt I received good medical care during this encounter")through study completion, an average of 1 year

    Survey responses will be summarized by ordinal category as counts with percentages, separately by group. Will separately estimate the proportion of each ordinal level of each group with 95% confidence interval.